Noa Shafran
Impact in
-
- Antibiotic Use and Resistance
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Papers in
-
- COVID-19 Clinical Research Studies 3
- Antifungal resistance and susceptibility 1
-
- Respiratory viral infections research 2
- Co-authors
- Amir Shlomai (4 shared papers)Ella H. Sklan (2 shared papers)Haim Ben‐Zvi (2 shared papers)Elad Goldberg (2 shared papers)Inbal Shafran (2 shared papers)Ilan Krause (1 shared paper)Liron Sheena (1 shared paper)Shlomo Almog (1 shared paper)
- Journals
- Scientific Reports (1 paper)Critical Care (1 paper)Clinical Breast Cancer (1 paper)BMC Cancer (1 paper)JHEP Reports (1 paper)
- Partner nations
- IsraelAustriaUnited States
In The Last Decade
Noa Shafran
7 papers receiving 252 citations
Peers
Comparison fields: 5 of 69
- Applied Microbiology and Biotechnology 19
- Infectious Diseases 77
- Critical Care and Intensive Care Medicine 13
- Pharmacology 25
- Molecular Medicine 10
Countries citing papers authored by Noa Shafran
This map shows the geographic impact of Noa Shafran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Shafran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Shafran more than expected).
Fields of papers citing papers by Noa Shafran
This network shows the impact of papers produced by Noa Shafran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Shafran. The network helps show where Noa Shafran may publish in the future.
Co-authors
The 25 scholars most cited alongside Noa Shafran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 130 | |
| 2 | 1985 | 56 | |
| 3 | 2020 | 30 | |
| 4 | 2021 | 22 | |
| 5 | 2017 | 13 | |
| 6 | 2015 | 4 | |
| 7 | 2025 | 1 |
About Noa Shafran
Noa Shafran is a scholar working on Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Cell Biology, having authored 7 papers that have together received 256 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Respiratory viral infections research (2 papers), Antibiotic Use and Resistance (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Plant Pathogens and Fungal Diseases (1 paper), Respiratory Support and Mechanisms (1 paper), Cardiac Arrhythmias and Treatments (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Infectious Diseases (77 citations), Critical Care and Intensive Care Medicine (13 citations), Pharmacology (25 citations) and Molecular Medicine (10 citations). Noa Shafran has collaborated with scholars based in Israel, Austria and United States. Frequent co-authors include Amir Shlomai, Ella H. Sklan, Haim Ben‐Zvi, Elad Goldberg, Inbal Shafran, Ilan Krause, Liron Sheena, Shlomo Almog, Hillel Halkin and Peter H. Weiss. Their work appears in journals such as Scientific Reports, Critical Care, Clinical Breast Cancer, BMC Cancer and JHEP Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.